Towa Pharmaceutical Co Ltd
TSE:4553
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Towa Pharmaceutical Co Ltd
Change in Working Capital
Towa Pharmaceutical Co Ltd
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
Change in Working Capital
-¥16.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Change in Working Capital
-¥118.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Change in Working Capital
-¥272.8B
|
CAGR 3-Years
-128%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Change in Working Capital
-¥184.7B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Change in Working Capital
-¥259B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-23%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Change in Working Capital
-¥160.6B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
-4%
|
|
Towa Pharmaceutical Co Ltd
Glance View
Towa Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. The company is headquartered in Kadoma-Shi, Osaka-Fu and currently employs 3,456 full-time employees. The company went IPO on 2004-04-05. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. The company is a drug with the same effect, usage and dosage. The firm is involved in the sale and outsourced manufacture of products and generic drugs. The firm is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The firm is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
See Also
What is Towa Pharmaceutical Co Ltd's Change in Working Capital?
Change in Working Capital
-16.3B
JPY
Based on the financial report for Dec 31, 2025, Towa Pharmaceutical Co Ltd's Change in Working Capital amounts to -16.3B JPY.
What is Towa Pharmaceutical Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 10Y
0%
Over the last year, the Change in Working Capital growth was 57%. The average annual Change in Working Capital growth rates for Towa Pharmaceutical Co Ltd have been 8% over the past three years , -5% over the past five years .
